Pakistan Business News API

{
    "totalArticles": 345462,
    "articles": [
        {
            "id": "a531cfce95ecb057a87cb4abf7c5da44",
            "title": "Kansas woman loses $255,000 in gold in FBI impersonation scam",
            "description": "An 84-year-old Kansas woman thought she was saving her life savings. Instead, she was handing it over.Over several months, the Sedgwick County resident was tricked into buying more than $255,000...",
            "content": "An 84-year-old Kansas woman thought she was saving her life savings. Instead, she was handing it over.\nOver several months, the Sedgwick County resident was tricked into buying more than $255,000 worth of gold after phone scammers convinced her they ... [1121 chars]",
            "url": "https://www.thenews.com.pk/latest/1388892-kansas-woman-loses-255000-in-gold-in-fbi-impersonation-scam",
            "image": "https://www.thenews.com.pk/assets/uploads/2026-01-18/1388892_120028_updates.jpg",
            "publishedAt": "2026-01-18T19:00:00Z",
            "lang": "en",
            "source": {
                "id": "d6d8d1da5b3ea3eb10f02262522a0d6d",
                "name": "The News International",
                "url": "https://www.thenews.com.pk"
            }
        },
        {
            "id": "c141bf50eac14089361cd5202db157b7",
            "title": "FDA's new expedited drug program raises legal questions and concerns",
            "description": "The FDA commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the agency.",
            "content": "WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the agency, stoking worries that the plan may run afoul of ... [9932 chars]",
            "url": "https://www.pbs.org/newshour/health/fdas-new-expedited-drug-program-raises-legal-questions-and-concerns",
            "image": "https://d3i6fh83elv35t.cloudfront.net/static/2026/01/2026-01-15T224228Z_1773975969_RC29XGAXTHOM_RTRMADP_3_HEALTH-USA-FDA-VOUCHERS-1024x673.jpg",
            "publishedAt": "2026-01-18T18:04:59Z",
            "lang": "en",
            "source": {
                "id": "7194247a4f44906ac877ec001837157c",
                "name": "PBS",
                "url": "https://www.pbs.org"
            }
        },
        {
            "id": "1fab194102b636cc0fdb7d375c396f1e",
            "title": "Intensified First-Line Therapy for dMMR/MSI-H mCRC: Nursing Implications of the COMMIT Trial",
            "description": "Findings from the phase 3 COMMIT study show that adding mFOLFOX6 and bevacizumab to atezolizumab significantly improves PFS in patients with dMMR/MSI-H mCRC.",
            "content": "Newly released data from the phase 3 COMMIT study (NRG-GI004/SWOG-S1610) offer a promising strategy for managing patients with previously untreated mismatch repair-deficient (dMMR) or microsatellite instability–high (MSI-H) metastatic colorectal canc... [3927 chars]",
            "url": "https://www.oncnursingnews.com/view/intensified-first-line-therapy-for-dmmr-msi-h-mcrc-nursing-implications-of-the-commit-trial",
            "image": "https://cdn.sanity.io/images/0vv8moc6/oncnurse/a89cdf26783188149ede868f7c8e9b776980c448-1920x1080.jpg",
            "publishedAt": "2026-01-18T15:09:12Z",
            "lang": "en",
            "source": {
                "id": "f4731bea6b160e6c4933502d0a66839a",
                "name": "Oncology Nursing News",
                "url": "https://www.oncnursingnews.com"
            }
        }
    ]
}